A detailed history of Signaturefd, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 4,680 shares of ADMA stock, worth $99,122. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,680
Previous 5,503 14.96%
Holding current value
$99,122
Previous $61,000 52.46%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$11.21 - $20.03 $9,225 - $16,484
-823 Reduced 14.96%
4,680 $93,000
Q1 2024

May 03, 2024

BUY
$4.4 - $6.74 $686 - $1,051
156 Added 2.92%
5,503 $36,000
Q2 2023

Aug 01, 2023

SELL
$3.12 - $4.22 $127 - $173
-41 Reduced 0.76%
5,347 $19,000
Q1 2023

Apr 28, 2023

BUY
$3.01 - $3.87 $1,468 - $1,888
488 Added 9.96%
5,388 $17,000
Q3 2022

Nov 08, 2022

BUY
$2.03 - $2.86 $9,946 - $14,014
4,900 New
4,900 $12,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.